期刊文献+

沉默p110β基因表达对前列腺癌细胞生物学行为的影响

Effect of silencing the expression of p110β on the biology behavior of prostate cancer cells
下载PDF
导出
摘要 目的:通过RNA干涉技术沉默p110β在前列腺癌细胞C4-2中的表达,观察p110β的表达抑制对前列腺癌增殖、侵袭、转移的影响。方法:根据p110β基因序列设计并合成的siRNA片段(p110β-siRNA)转染C4-2细胞,利用荧光实时定量qRT-PCR检测细胞中p110β基因mRNA水平的变化;Western blot检测p110β蛋白水平的变化;MTT法检测C4-2细胞增殖情况;Transwell小室侵袭实验检测C4-2细胞侵袭能力变化;细胞划痕试验检测对C4-2细胞迁移能力的影响。结果:p110β-siRNA下调了C4-2细胞中p110βmRNA水平与蛋白水平的表达,转染细胞的增殖和侵袭迁移能力下降。结论:p110β-siRNA能够下调p110β的表达,并有效抑制C4-2前列腺癌细胞的增殖及其迁移侵袭能力。因此,沉默p110β的表达可使前列腺细胞恶性程度降低。 Objective:To explore the effects of silencing p110β on proliferation and invasion and metastasis of huaman prostate cancer cell line C4-2.Methods:To design and synthesis of siRNA fragments (p110β-siRNA) according to p110β gene sequence and transfect p110β-siRNA into C4-2 cells;Using real time fluorescent quantitative qRT-PCR to detect the mRNA expression; Western blot technology to detect protein expression level ; the proliferation of C4-2 cells was analyzed by MTT ;Transwell cell invasion assay and wound scratch assay for detecting the invasion and metastasis ability of C4-2 cells.Results:p110β-siRNA down regulated mRNA and protein expression level of p110β gene in C4-2 cells and inhibited the proliferation,migration and invasion ability of C4-2 cells.Conclusion:p110β-siRNA could down regulate the expression of p110β,and effectively inhibit cell proliferation,migration and invasion abilities of C4-2 cells,p110β may be a target gene for the therapy of prostate cancer.
出处 《现代肿瘤医学》 CAS 2013年第9期1950-1952,共3页 Journal of Modern Oncology
关键词 p110β 前列腺癌 增殖 侵袭 转移 p110β prostate cancer proliferation migration invasion
  • 相关文献

参考文献8

  • 1Scher HI, Sawye: CL. Biology of progressive, castration - resistant prostate cancer:directed therapies targeting the androgen -reeeptor signaling axis [ J ]. J Clin Oncoi ,2005,23 ( 32 ) :8253 - 826 I.
  • 2Jeffery P, Patricia Hartge, Sc D, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews[ J 1. N Engl .I Med, 1997,336 : 1401 - 1408.
  • 3Murillo H, Huang H, Schmidt LJ, et al. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the an- drogen refractory state [ J ]. Endocrinology, 2001,142 ( 11 ) :4795 - 4805.
  • 4于殿君,孙晓文,施云峰,刘世博.前列腺癌雄激素受体和PI3K/Akt信号通路相互作用研究进展[J].现代生物医学进展,2011,11(1):180-183. 被引量:12
  • 5Vogt PK, Kang S, Eisliger MA, et al. Cancer- specific mutations in phosphatidylinositol 3 - kinase [ J 1- Trends Biochem Sci, 2007,32 (7) :342 -349.
  • 6Hirsch E, Costa C, Ciraolo E. Phosphoinositide 3 -kinases as a common platform for multi - hormone signaling[J]. J Endocrinol, 2007,194 (2) :243 - 256.
  • 7Q Zhu ,H Youn ,J Tang,et al. Phosphoinositide 3 - OH kinase p85a and p110b are essential for androgen receptor transactivation and tumor progression in prostate cancers[J] Oncogene, 2008,27 ( 3 ) : 4569 - 4579.
  • 8Yu JY, Deruiter SL, Turner DL. RNA interference by expression of short- interfering RNAs and hairpin RNAs in mammalian cells [ J ]. Proc Natl Aead Sei USA ,2002,99 ( 9 ) :6047 - 6052.

二级参考文献33

  • 1Brunet A, Bonni A, Zigrnond Met al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor [J]. Cell, 1999, 96(3), 857-868.
  • 2Dong X, Chen C, Sun X et al. FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer[J].Cancer Res,2006, 66(1),6998-7006.
  • 3Datta S, Dudek H,Tao X. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J]. Cell, 1997, 91(1), 231- 241.
  • 4Yamaguchi H, Wang H. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax eonformational change [J]. Oncogene, 2001, 20(2), 7779-7786.
  • 5Plas D, Talapatra S, Edinger Aet al. Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondfial physiology[J]. J. Biol. Chem, 2001,276(5), 12041-12048.
  • 6Zhou B, Hung M. Novel targets of Akt, p21 (Cipl/WAF1), and MDM2. Semin. [J]. Oncol, 2002, 29(2): 62-70.
  • 7Viglietto G, Motti M, Bruni P et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27 (Kipl) by PKB/Akt- mediated phosphorylation in breast cancer [J]. Nat Med, 2002, 8(4):1136-1144.
  • 8Graft J, Konicek B, Wang Z et al. Increased AKT activity con-tributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kipl expression[J]. J. Biol. Chem, 2000, 275(1):24500-24505.
  • 9Thant A, Nawa A, Kikkawa F, et al. Fibronectin activates ma-trix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells [J]. Clin Exp Metastasis, 2000, 18(3) 423-428.
  • 10Koul D, Shen R, Garyali A et al. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated anglogenesis in prostate cancer[J]. Int J Oneol, 2002, 21(3): 469-475.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部